HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Selsun Blue Purchase Provides Entry Into Five New Foreign Markets

This article was originally published in The Rose Sheet

Executive Summary

Line extensions and a keen marketing push are among the growth tactics Chattem expects to pursue when it brings Selsun Blue into its consumer health portfolio. Chattem has agreed to purchase the anti-dandruff line from Abbott Labs subsidiary Ross Products

You may also be interested in...



Gold Bond, Selsun Line Extensions To Help Drive Chattem’s 2007 Sales

Chattem will rely on the launch of line extensions under core brands to drive revenue growth in 2007, the company announced during an Oct. 10 third quarter analyst call

Gold Bond, Selsun Line Extensions To Help Drive Chattem’s 2007 Sales

Chattem will rely on the launch of line extensions under core brands to drive revenue growth in 2007, the company announced during an Oct. 10 third quarter analyst call

Chattem Advertising Strategy Relies On “Guerrilla” Tactics – CEO Guerry

Chattem's advertising strategy focuses on acquiring media time "as a guerilla buyer as opposed to a big buyer," CEO Zan Guerry maintained at a Banc of America Securities consumer conference in New York April 8-10

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel